Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

NCT07157787 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: ALXN1920
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]